About this episode

The episode discusses the latest insights and treatment approaches for metastatic triple-negative breast cancer with expert guests.

Featuring perspectives from Dr Kevin Punie and Dr Tiffany A Traina, including the following topics: Introduction: Where We Are; Where We’re Heading (0:00) First-Line Treatment of BRCA Wild-Type Disease (9:14) First-Line Treatment of BRCA-Mutant Disease (38:48) Novel Approaches (47:49) CME information and select publications

People in this episode

Host: Dr. Neil Love

Guests: Dr Kevin Punie, Dr Tiffany A Traina

Topics covered

• Metastatic Triple-Negative Breast Cancer
• First-Line Treatment
• BRCA Wild-Type Disease
• BRCA-Mutant Disease
• Novel Approaches

Keywords

• metastatic breast cancer
• triple-negative
• BRCA
• first-line treatment
• novel approaches

Mentioned in this episode

Organizations: BRCA

More episodes of Breast Cancer Update

• HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy · July 18, 2026 · 46 min
• Localized HR-Positive Breast Cancer — Year in Review Series on Relevant New Datasets and Advances · July 13, 2026 · 58 min
• For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress · July 10, 2026 · 1h 29m
• Antibody-Drug Conjugates in the Management of Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting · July 8, 2026 · 2h 0m
• HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit · June 29, 2026 · 1h 39m
• HER2-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit · June 23, 2026 · 52 min

Explore listener stats, chart rankings, contacts and more on the Breast Cancer Update podcast page.